Bausch Health Companies BHC
NYSE BHC
$6.82 -0.07 (-1.09%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026)

Bausch Health Companies (BHC) posted Amortization of Deferred Charges of $21.0 million for Q2 2026, up 50.0% sequentially from $14.0 million in Q1 2026, and down 48.78% YoY from $41.0 million in Q2 2025.

Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Amortization of Deferred Charges for 18 years, with the latest figure at $21.0 million in Q2 2026.

  • Quarterly Amortization of Deferred Charges fell 48.78% year-over-year to $21.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $73.0 million (down 12.05% YoY) and the FY2025 annual result came in at $94.0 million, up 70.91% from the prior year.
  • Amortization of Deferred Charges improved to $21.0 million in Q2 2026 per BHC's latest filing, from $14.0 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $50.0 million in Q2 2022 and troughed at $11.0 million in Q1 2023.
  • A 5-year average of $19.3 million and a median of $14.0 million in 2022 frame the typical range for Amortization of Deferred Charges.
  • The sharpest annual moves came in 2022 and 2023: Amortization of Deferred Charges surged 316.67% in 2022, then tumbled 76.0% in 2023.
  • Over 5 years, Amortization of Deferred Charges stood at $13.0 million in 2022, then rose by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then jumped by 57.14% to $22.0 million in 2025, then decreased by 4.55% to $21.0 million in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $21.0 million, $14.0 million, and $22.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Bausch Health Companies 2.56 Bn 725.13 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.00 Mn
Jun 30, 2026 21.00 Mn
Mar 31, 2026 14.00 Mn
Mar 31, 2026 14.00 Mn
Dec 31, 2025 22.00 Mn
Dec 31, 2025 22.00 Mn
Sep 30, 2025 16.00 Mn
Sep 30, 2025 16.00 Mn
Jun 30, 2025 41.00 Mn
Jun 30, 2025 41.00 Mn
Mar 31, 2025 15.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 14.00 Mn
Dec 31, 2024 14.00 Mn
Sep 30, 2024 13.00 Mn
Sep 30, 2024 13.00 Mn
Jun 30, 2024 14.00 Mn
Jun 30, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn